<DOC>
	<DOC>NCT01200576</DOC>
	<brief_summary>This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Madagascar. It will be implemented by Marie Stopes Madagascar with technical support from Marie Stopes International and FHI. 300 women of reproductive age who selected Zarin as their primary method of contraception will be enrolled in the study at the MSM outreach sites and static clinics.</brief_summary>
	<brief_title>A Prospective Observational Study of the Clinical Performance of Zarin in Madagascar</brief_title>
	<detailed_description>This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Madagascar. It will be implemented by Marie Stopes Madagascar with technical support from Marie Stopes International and FHI. 300 women of reproductive age who selected Zarin as their primary method of contraception will be enrolled in the study at the MSM outreach sites and static clinics.</detailed_description>
	<criteria>be a participant of the MSM service evaluation and continue using Zarin at 3 months agree at the time of Zarin insertion to be contacted regarding an opportunity to participate in more research related to the implant</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>CRF: Case Report Form</keyword>
	<keyword>DM: Data Management</keyword>
	<keyword>FHI: FHI (formerly known as Family Health International)</keyword>
	<keyword>IRB: Institutional Review Board</keyword>
	<keyword>IUD: Intra-uterine Device</keyword>
	<keyword>LTPM: Long-term and Permanent Contraceptive Methods</keyword>
	<keyword>MSI: Marie Stopes International</keyword>
	<keyword>MSM: Marie Stopes Madagascar</keyword>
	<keyword>PHSC: Protection of Human Subjects Committee</keyword>
	<keyword>PI: Principal Investigator</keyword>
	<keyword>SAE: Serious Adverse Event</keyword>
	<keyword>Sino-Implant (II)</keyword>
	<keyword>SOP: Standard Operating Procedure</keyword>
	<keyword>Zarin</keyword>
</DOC>